Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI
Details : Insilico Medicine achieves industry first nominating preclinical candidate for idiopathic pulmonary fibrosis with both novel drug target and novel molecule discovered by artificial intelligence.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 24, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable